195 related articles for article (PubMed ID: 17285596)
1. Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis.
Yoshizawa S; Matsuoka K; Inoue N; Takaishi H; Ogata H; Iwao Y; Mukai M; Fujita T; Kawakami Y; Hibi T
Inflamm Bowel Dis; 2007 Jul; 13(7):865-73. PubMed ID: 17285596
[TBL] [Abstract][Full Text] [Related]
2. Serum p53 antibodies in patients affected with ulcerative colitis.
Cioffi M; Riegler G; Vietri MT; Pilla P; Caserta L; Carratù R; Sica V; Molinari AM
Inflamm Bowel Dis; 2004 Sep; 10(5):606-11. PubMed ID: 15472522
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations in colitis-associated colorectal neoplasia: study from a low prevalence area using magnifying chromo colonoscopy.
Shivakumar BM; Kumar BL; Bhat G; Suvarna D; Rao L; Pai CG; Satyamoorthy K
J Crohns Colitis; 2012 Jul; 6(6):647-54. PubMed ID: 22398042
[TBL] [Abstract][Full Text] [Related]
6. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
[TBL] [Abstract][Full Text] [Related]
7. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
8. Uselessness of Serum p53 Antibody for Detecting Colitis-associated Cancer in the Era of Immunosuppressive Therapy.
Toritani K; Kimura H; Kunisaki R; Watanabe J; Kunisaki C; Ishibe A; Chiba S; Inayama Y; Endo I
In Vivo; 2020; 34(2):723-728. PubMed ID: 32111776
[TBL] [Abstract][Full Text] [Related]
9. Potential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinoma.
Zdravkovic ND; Jovanovic IP; Radosavljevic GD; Arsenijevic AN; Zdravkovic ND; Mitrovic SLj; Arsenijevic NN
Int J Med Sci; 2014; 11(9):936-47. PubMed ID: 25076849
[TBL] [Abstract][Full Text] [Related]
10. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
12. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
[TBL] [Abstract][Full Text] [Related]
13. Humoral response to p53 in human colorectal tumors: a prospective study of 1,209 patients.
Tang R; Ko MC; Wang JY; Changchien CR; Chen HH; Chen JS; Hsu KC; Chiang JM; Hsieh LL
Int J Cancer; 2001 Dec; 94(6):859-63. PubMed ID: 11745489
[TBL] [Abstract][Full Text] [Related]
14. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
15. What is the likelihood of colorectal cancer when surgery for ulcerative-colitis-associated dysplasia is deferred?
Murphy J; Kalkbrenner KA; Blas JV; Pemberton JH; Landmann RG; Young-Fadok TM; Etzioni DA
Colorectal Dis; 2016 Jul; 18(7):703-9. PubMed ID: 26921877
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.
Ünal NG; Özütemiz Ö; Tekin F; Turan İ; Osmanoğlu N
Turk J Gastroenterol; 2019 Feb; 30(2):139-147. PubMed ID: 30460897
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
Garrity-Park M; Loftus EV; Sandborn WJ; Smyrk TC
Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
[TBL] [Abstract][Full Text] [Related]
18. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
19. Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case.
Sada H; Shimomura M; Hinoi T; Egi H; Kawaguchi K; Yano T; Niitsu H; Saitou Y; Sawada H; Miguchi M; Adachi T; Ohdan H
World J Surg Oncol; 2015 Mar; 13():123. PubMed ID: 25888857
[TBL] [Abstract][Full Text] [Related]
20. p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia.
Hamouda HE; Zakaria SS; Ismail SA; Khedr MA; Mayah WW
World J Gastroenterol; 2011 May; 17(19):2417-23. PubMed ID: 21633642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
